Literature DB >> 8565266

Managing lymphoedema.

P S Mortimer1.   

Abstract

Lymphoedema is perceived by clinicians in the UK as a rare condition for which there is no effective treatment. I would like to argue that lymphoedema is in fact a common condition which is misunderstood and often poorly managed. To explain further the basic physiology of oedema has to be considered.

Entities:  

Mesh：

Year:  1995        PMID： 8565266     DOI： 10.1111/j.1365-2230.1995.tb02665.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


  5 in total

1.  Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia.

Authors:  Fiona Connell; Kamini Kalidas; Pia Ostergaard; Glen Brice; Tessa Homfray; Lesley Roberts; David J Bunyan; Sally Mitton; Sahar Mansour; Peter Mortimer; Steve Jeffery
Journal:  Hum Genet       Date:  2009-11-13       Impact factor: 4.132

2.  Use of compression garments by women with lymphoedema secondary to breast cancer treatment.

Authors:  E Longhurst; E S Dylke; S L Kilbreath
Journal:  Support Care Cancer       Date:  2018-02-19       Impact factor: 3.603

3.  A gene for lymphedema-distichiasis maps to 16q24.3.

Authors:  J Mangion; N Rahman; S Mansour; G Brice; J Rosbotham; A H Child; V A Murday; P S Mortimer; R Barfoot; A Sigurdsson; S Edkins; M Sarfarazi; K Burnand; A L Evans; T O Nunan; M R Stratton; S Jeffery
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

4.  Effect of acute exercise on upper-limb volume in breast cancer survivors: a pilot study.

Authors:  Margaret L McNeely; Kristin L Campbell; Kerry S Courneya; John R Mackey
Journal:  Physiother Can       Date:  2009-11-12       Impact factor: 1.037

5.  A novel mutation in the conserved sequence of vascular endothelial growth factor receptor 3 leads to primary lymphoedema.

Authors:  Ting Dai; Bohan Li; Bo He; Liwei Yan; Liqiang Gu; Xiaolin Liu; Jian Qi; Ping Li; Xiang Zhou
Journal:  J Int Med Res       Date:  2018-06-13       Impact factor: 1.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.